These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18265474)

  • 21. Prevalence of the metabolic syndrome and associated factors in korean cancer survivors.
    Lee JY; Park NH; Song YS; Park SM; Lee HW; Kim KH; Choi KH
    Asian Pac J Cancer Prev; 2013; 14(3):1773-80. PubMed ID: 23679272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
    Hammarsten J; Högstedt B
    Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity, metabolic syndrome, and prostate cancer.
    Hsing AW; Sakoda LC; Chua S
    Am J Clin Nutr; 2007 Sep; 86(3):s843-57. PubMed ID: 18265478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 24-month metabolic benefits of the healthy living partnerships to prevent diabetes: A community-based translational study.
    Pedley CF; Case LD; Blackwell CS; Katula JA; Vitolins MZ
    Diabetes Metab Syndr; 2018 May; 12(3):215-220. PubMed ID: 28964720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and cancer: holistic or reductionist?
    Esposito K; Capuano A; Giugliano D
    Endocrine; 2014 Apr; 45(3):362-4. PubMed ID: 24065310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.
    Bray GA; Bellanger T
    Endocrine; 2006 Feb; 29(1):109-17. PubMed ID: 16622298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.
    Manco M
    J Am Coll Nutr; 2011 Oct; 30(5):295-303. PubMed ID: 22081615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome, inflammation and atherosclerosis.
    Paoletti R; Bolego C; Poli A; Cignarella A
    Vasc Health Risk Manag; 2006; 2(2):145-52. PubMed ID: 17319458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The underlying mechanisms for development of hypertension in the metabolic syndrome.
    Yanai H; Tomono Y; Ito K; Furutani N; Yoshida H; Tada N
    Nutr J; 2008 Apr; 7():10. PubMed ID: 18416854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What do we currently know about metabolic syndrome and atrial fibrillation?
    Tadic M; Ivanovic B; Cuspidi C
    Clin Cardiol; 2013 Nov; 36(11):654-62. PubMed ID: 23788255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Syndrome and the Risk of Gastrointestinal Cancer: a Case-Control Study.
    Tahergorabi Z; Moodi M; Zardast M; Ghayravani Z; Tavakoli T
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2205-2210. PubMed ID: 30139226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A major health hazard: the metabolic syndrome.
    Isomaa B
    Life Sci; 2003 Sep; 73(19):2395-411. PubMed ID: 12954449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.
    Cantiello F; Cicione A; Salonia A; Autorino R; De Nunzio C; Briganti A; Gandaglia G; Dell'Oglio P; Capogrosso P; Damiano R
    Int J Urol; 2015 Jan; 22(1):22-32. PubMed ID: 25345683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome and risk of cancer: a study protocol of case-control study using data from the Information System for the Development of Research in Primary Care (SIDIAP) in Catalonia.
    Puente D; López-Jiménez T; Cos-Claramunt X; Ortega Y; Duarte-Salles T
    BMJ Open; 2019 Jun; 9(6):e025365. PubMed ID: 31201184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal damage in the metabolic syndrome (MetSx): Disorders implicated.
    Joyce T; Chirino YI; Natalia MT; Jose PC
    Eur J Pharmacol; 2018 Jan; 818():554-568. PubMed ID: 29162432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and comorbidities of double diabetes.
    Merger SR; Kerner W; Stadler M; Zeyfang A; Jehle P; Müller-Korbsch M; Holl RW; ;
    Diabetes Res Clin Pract; 2016 Sep; 119():48-56. PubMed ID: 27449710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome management.
    Stone NJ; Schmeltz LR
    Expert Opin Pharmacother; 2007 Sep; 8(13):2059-75. PubMed ID: 17714060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic medical conditions and metabolic syndrome as risk factors for incidence of major depressive disorder: A longitudinal study based on 4.7 million adults in South Korea.
    Han KM; Kim MS; Kim A; Paik JW; Lee J; Ham BJ
    J Affect Disord; 2019 Oct; 257():486-494. PubMed ID: 31319340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study.
    Lee JA; Yoo JE; Park HS
    Breast Cancer Res Treat; 2017 Apr; 162(2):389-393. PubMed ID: 28150128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.